Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) is expanding its presence within a major national healthcare system.
The company disclosed the placement of its flagship Perimeter S-Series OCT system at a new hospital site in North Texas.
The Perimeter S-Series OCT (Optical Coherence Tomography) system is the company's flagship product, offering cross-sectional, real-time margin visualization of excised tissue specimens in the operating room.
Adrian Mendes, Perimeter's CEO, emphasized the importance of this expansion, stating, "Our continued growth within a major national healthcare system underscores the recognition of the value our surgeon customers place on the Perimeter S-Series in their operating rooms and the potential benefits for their patients."
Mendes further highlighted the potential of combining surgeons' clinical expertise with OCT technology to reduce repeat surgeries, particularly in cases where cancer is left behind, expressing confidence that Perimeter's innovative technology can establish itself as the standard of care in cancer surgery.
With image resolution ten times higher than X-ray and ultrasound, and a hundred times greater than MRI, the medical imaging system could hold significant promise in improving surgical outcomes.
Headquartered in Toronto, Canada, and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) is dedicated to advancing cancer surgery through ultra-high-resolution, real-time imaging tools to address unmet medical needs.
In addition to the S-Series, Perimeter is advancing its investigational Perimeter B-Series OCT with ImgAssist AI, designated as a breakthrough device, through a pivotal clinical trial supported by a grant of up to US$7.4 million from the Cancer Prevention and Research Institute of Texas.